Multiple Assemblies exist for SMTL entry 8p5i
Kinase domain of mutant human ULK1 in complex with compound XMD-17-51; X-RAY DIFFRACTION 1.83 Å

	SMTL ID 8p5i.1 Ligands 5,11-dimethyl-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimido[4,5-b][1,4]benzodiazepin-6-one; MAGNESIUM ION; SODIUM ION Polypeptides Serine/threonine-protein kinase ULK1 Oligo-state monomer
	SMTL ID 8p5i.2 Ligands 5,11-dimethyl-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimido[4,5-b][1,4]benzodiazepin-6-one; GLYCEROL; MAGNESIUM ION; SODIUM ION Polypeptides Serine/threonine-protein kinase ULK1 Oligo-state monomer
	SMTL ID 8p5i.3 Ligands 5,11-dimethyl-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimido[4,5-b][1,4]benzodiazepin-6-one; GLYCEROL; MAGNESIUM ION Polypeptides Serine/threonine-protein kinase ULK1 Oligo-state monomer
	SMTL ID 8p5i.4 Ligands 5,11-dimethyl-2-[(1-piperidin-4-ylpyrazol-4-yl)amino]pyrimido[4,5-b][1,4]benzodiazepin-6-one; MAGNESIUM ION; SODIUM ION Polypeptides Serine/threonine-protein kinase ULK1 Oligo-state monomer